| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |